Asker Healthcare
Research Asker Healthcare (ASKER) on Bullrun: valuation model: 4.9% overvalued, market cap SEK 28.84B, P/E 46.2, dividend yield 0.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerASKER
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Distribution
- CurrencySEK
- Valuation signal4.9% overvalued
- Market capSEK 28.84B
- P/E46.2
- Dividend yield0.5%
- Financial periodQ4 2025
- RevenueSEK 4.68B
- Net incomeSEK 130.00M
- Free cash flowSEK 345.00M
- Gross margin41.3%
Valuation Snapshot
Bullrun's latest valuation model marks Asker Healthcare as 4.9% overvalued; latest market cap is SEK 28.84B; P/E is 46.2; dividend yield is 0.5%.
About Asker Healthcare
Asker Healthcare Group AB (publ) provides medical supplies, devices, and equipment and related solutions that support patient care. The company supplies and distributes fittings and equipment; veterinary equipment; surgical and diagnostic instruments; medical supplies and equipment for urology, ultrasound diagnostics, laser treatment, and regenerative medicine; medical equipment for operating rooms, polyclinics, and day surgeries; hygiene equipment; equipment and products for beauty clinics;
Frequently asked questions
Is Asker Healthcare overvalued or undervalued?
Bullrun's valuation model currently marks Asker Healthcare as 4.9% overvalued.
What is Asker Healthcare's market cap?
Asker Healthcare's market capitalization is SEK 28.84B.
What is Asker Healthcare's P/E ratio?
Asker Healthcare's price-to-earnings (P/E) ratio is 46.2.
Does Asker Healthcare pay a dividend?
Asker Healthcare has a dividend yield of 0.5%.
What does Asker Healthcare do?
Asker Healthcare Group AB (publ) provides medical supplies, devices, and equipment and related solutions that support patient care. The company supplies and distributes fittings and equipment; veterinary equipment; surgical and diagnostic instruments;